Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire

Neutral · Mirum Pharmaceutical google nasdaq Mon, 13 Jul 2026 20:01:00 UTC

You are being sent to the original publisher. FX Radar keeps this reference for market context and source discovery.